VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+25.81%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$241M
AUM Growth
+$50.3M
(+26%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17
Top Buys
| 1 |
Brookfield Renewable
BEPC
|
$1.83M |
| 2 |
Western Midstream Partners
WES
|
$1.11M |
| 3 |
Delek US
DK
|
$829K |
| 4 |
Viper Energy
VNOM
|
$789K |
| 5 |
Oneok
OKE
|
$751K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$1.61M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$1.13M |
| 3 |
AIV
Aimco
AIV
|
$1.11M |
| 4 |
Telefônica Brasil
VIV
|
$1.01M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$988K |
Sector Composition
| 1 | Healthcare | 29.53% |
| 2 | Real Estate | 18.96% |
| 3 | Energy | 16.61% |
| 4 | Materials | 11.31% |
| 5 | Utilities | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Replimune Group
REPL
$494M
| $258K | 0.11% |
+6,769
| New | +$258K |
|
302
Invesco Senior Income Trust
VVR
$555M
| $258K | 0.11% |
64,827
-10,973
| -14% | -$43.7K |
|
|
AGEN
303
Agenus
AGEN
$138M
| $256K | 0.11% |
4,096
-404
| -9% | -$25.3K |
|
304
Repare Therapeutics
RPTX
$72.6M
| $256K | 0.11% |
+7,469
| New | +$256K |
|
|
RUBY
305
DELISTED
Rubius Therapeutics, Inc
RUBY
| $256K | 0.11% |
33,793
-17,070
| -34% | -$129K |
|
306
Dynavax Technologies
DVAX
$1.18B
| $254K | 0.11% |
57,062
+3,078
| +6% | +$13.7K |
|
307
Novavax
NVAX
$1.28B
| $254K | 0.11% |
2,275
-4,491
| -66% | -$501K |
|
308
BlackRock Floating Rate Income Trust
BGT
$317M
| $253K | 0.11% |
21,455
-2,514
| -10% | -$29.6K |
|
|
PHD
309
Pioneer Floating Rate Fund
PHD
$123M
| $253K | 0.11% |
24,790
-5,042
| -17% | -$51.5K |
|
310
BlackRock Limited Duration Income Trust
BLW
$548M
| $252K | 0.1% |
15,840
-1,140
| -7% | -$18.1K |
|
311
Wave Life Sciences
WVE
$1.32B
| $252K | 0.1% |
32,032
+16
| +0% | +$126 |
|
312
Inovio Pharmaceuticals
INO
$148M
| $251K | 0.1% |
+2,362
| New | +$251K |
|
313
Voyager Therapeutics
VYGR
$235M
| $251K | 0.1% |
35,079
+9,668
| +38% | +$69.2K |
|
314
FibroGen
FGEN
$48.9M
| $249K | 0.1% |
269
-54
| -17% | -$50K |
|
315
Viking Therapeutics
VKTX
$3.03B
| $248K | 0.1% |
43,966
+1,459
| +3% | +$8.23K |
|
316
Atara Biotherapeutics
ATRA
$90.7M
| $247K | 0.1% |
503
-811
| -62% | -$398K |
|
317
CytomX Therapeutics
CTMX
$376M
| $245K | 0.1% |
37,343
-1,378
| -4% | -$9.04K |
|
|
AFMD
318
DELISTED
Affimed
AFMD
| $244K | 0.1% |
+4,197
| New | +$244K |
|
319
Pliant Therapeutics
PLRX
$114M
| $244K | 0.1% |
+10,759
| New | +$244K |
|
320
XBiotech
XBIT
$89M
| $244K | 0.1% |
15,584
-7,592
| -33% | -$119K |
|
321
CEL-SCI Corp
CVM
$72.2M
| $243K | 0.1% |
695
-100
| -13% | -$35K |
|
322
Vir Biotechnology
VIR
$732M
| $242K | 0.1% |
9,044
+43
| +0.5% | +$1.15K |
|
|
EVF
323
Eaton Vance Senior Income Trust
EVF
$101M
| $241K | 0.1% |
37,892
-5,238
| -12% | -$33.3K |
|
324
Alaunos Therapeutics
TCRT
$4.27M
| $241K | 0.1% |
636
-25
| -4% | -$9.47K |
|
325
RAPT Therapeutics
RAPT
$214M
| $240K | 0.1% |
1,519
-271
| -15% | -$42.8K |
|